Conference paper
Cancer Research, vol. 79, The American Association for Cancer Research, 2019, pp. 991--991
APA
Click to copy
Jasper, S. L., Skarupa, E. B., Cummings, B. S., & Arnold, R. D. (2019). Secretory phospholipase A2 as a trigger for drug release in the treatment of triple-negative breast cancer. In Cancer Research (Vol. 79, pp. 991–991). The American Association for Cancer Research.
Chicago/Turabian
Click to copy
Jasper, Shanese L, Elena B Skarupa, Brian S Cummings, and Robert D Arnold. “Secretory Phospholipase A2 as a Trigger for Drug Release in the Treatment of Triple-Negative Breast Cancer.” In Cancer Research, 79:991–991. The American Association for Cancer Research, 2019.
MLA
Click to copy
Jasper, Shanese L., et al. “Secretory Phospholipase A2 as a Trigger for Drug Release in the Treatment of Triple-Negative Breast Cancer.” Cancer Research, vol. 79, The American Association for Cancer Research, 2019, pp. 991–91.
BibTeX Click to copy
@inproceedings{jasper2019a,
title = {Secretory phospholipase A2 as a trigger for drug release in the treatment of triple-negative breast cancer},
year = {2019},
journal = {Cancer Research},
pages = {991--991},
publisher = {The American Association for Cancer Research},
volume = {79},
author = {Jasper, Shanese L and Skarupa, Elena B and Cummings, Brian S and Arnold, Robert D}
}